ShunzymeX addresses inherent challenges in traditional microbial downstream purification due to microbial-expressed protein diversity.

From analytical control through downstream processes to manufacturing, BsAbs present challenges in protein expression, purity, and stability.

FUJIFILM Biotechnologies introduces ShunzymeX precision purification technology for downstream processing of complex biologics: Teessid, United Kingdom Thursday, March 5, 2026, 16 ...

Innovators are increasingly focused on whether outsourced partners can help them make better decisions earlier, before ...

Spec-Driven Development sets written specs before AI coding; a 4-step flow links requirements, design docs, tests, and QA.

Cytiva expands Fast Trak process development and validation services facility in India: Our Bureau, Bengaluru Thursday, February 26, 2026, 12:15 Hrs [IST] Cytiva, a Danaher compan ...

Demeetra AgBio (Demeetra) today announced the publication of a peer-reviewed research article in Biotechnology Progress validating the performance of its integrated cell line development (CLD) ...

SHANGHAI, Feb. 10, 2026 /PRNewswire/ -- AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms spanning the full ...

Discover the transformation of antibody-drug conjugates (ADCs) from experimental to essential in cancer therapy with new ...

As sponsors advanced more niche and personalized modalities, manufacturers were pushed to adopt holistic approaches to safety ...

"CES Launches Intelligent Workflow Automation within a New CES|BLUE UI/UX. " CES is continuously investing in its ...